Your browser doesn't support javascript.
loading
Prior vaccination promotes early activation of memory T cells and enhances immune responses during SARS-CoV-2 breakthrough infection.
Painter, Mark M; Johnston, Timothy S; Lundgreen, Kendall A; Santos, Jefferson J S; Qin, Juliana S; Goel, Rishi R; Apostolidis, Sokratis A; Mathew, Divij; Fulmer, Bria; Williams, Justine C; McKeague, Michelle L; Pattekar, Ajinkya; Goode, Ahmad; Nasta, Sean; Baxter, Amy E; Giles, Josephine R; Skelly, Ashwin N; Felley, Laura E; McLaughlin, Maura; Weaver, Joellen; Kuthuru, Oliva; Dougherty, Jeanette; Adamski, Sharon; Long, Sherea; Kee, Macy; Clendenin, Cynthia; da Silva Antunes, Ricardo; Grifoni, Alba; Weiskopf, Daniela; Sette, Alessandro; Huang, Alexander C; Rader, Daniel J; Hensley, Scott E; Bates, Paul; Greenplate, Allison R; Wherry, E John.
Afiliación
  • Painter MM; Institute for Immunology, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA.
  • Johnston TS; Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA.
  • Lundgreen KA; Immune Health, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA.
  • Santos JJS; Institute for Immunology, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA.
  • Qin JS; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
  • Goel RR; Immunology Graduate Group, University of Pennsylvania, Philadelphia, PA, USA.
  • Apostolidis SA; Department of Microbiology, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA.
  • Mathew D; Department of Microbiology, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA.
  • Fulmer B; Immune Health, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA.
  • Williams JC; Institute for Immunology, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA.
  • McKeague ML; Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA.
  • Pattekar A; Immune Health, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA.
  • Goode A; Institute for Immunology, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA.
  • Nasta S; Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA.
  • Baxter AE; Immune Health, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA.
  • Giles JR; Division of Rheumatology, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA.
  • Skelly AN; Institute for Immunology, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA.
  • Felley LE; Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA.
  • McLaughlin M; Institute for Immunology, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA.
  • Weaver J; Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA.
  • Kuthuru O; Immune Health, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA.
  • Dougherty J; Immune Health, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA.
  • Adamski S; Immune Health, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA.
  • Long S; Immune Health, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA.
  • Kee M; Institute for Immunology, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA.
  • Clendenin C; Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA.
  • da Silva Antunes R; Institute for Immunology, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA.
  • Grifoni A; Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA.
  • Weiskopf D; Parker Institute for Cancer Immunotherapy, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA.
  • Sette A; Institute for Immunology, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA.
  • Huang AC; Department of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Rader DJ; Division of Infectious Disease, Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA.
  • Hensley SE; Institute for Immunology, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA.
  • Bates P; Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA.
  • Greenplate AR; Department of Genetics, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA.
Nat Immunol ; 24(10): 1711-1724, 2023 Oct.
Article en En | MEDLINE | ID: mdl-37735592
ABSTRACT
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection of vaccinated individuals is increasingly common but rarely results in severe disease, likely due to the enhanced potency and accelerated kinetics of memory immune responses. However, there have been few opportunities to rigorously study early recall responses during human viral infection. To better understand human immune memory and identify potential mediators of lasting vaccine efficacy, we used high-dimensional flow cytometry and SARS-CoV-2 antigen probes to examine immune responses in longitudinal samples from vaccinated individuals infected during the Omicron wave. These studies revealed heightened spike-specific responses during infection of vaccinated compared to unvaccinated individuals. Spike-specific cluster of differentiation (CD)4 T cells and plasmablasts expanded and CD8 T cells were robustly activated during the first week. In contrast, memory B cell activation, neutralizing antibody production and primary responses to nonspike antigens occurred during the second week. Collectively, these data demonstrate the functionality of vaccine-primed immune memory and highlight memory T cells as rapid responders during SARS-CoV-2 infection.

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Nat Immunol Asunto de la revista: ALERGIA E IMUNOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Nat Immunol Asunto de la revista: ALERGIA E IMUNOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos